Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
5,315
Views
21
CrossRef citations to date
0
Altmetric
Back Matter

Development of CAR-T cell therapy for B-ALL using a point-of-care approach

Luiza de Macedo Abdoa Immunology and Tumor Biology Program - Research Coordination, Brazilian National Cancer Institute (INCA), Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0003-4381-9123View further author information
ORCID Icon,
Luciana Rodrigues Carvalho Barrosa Immunology and Tumor Biology Program - Research Coordination, Brazilian National Cancer Institute (INCA), Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0002-8633-716XView further author information
ORCID Icon,
Mariana Saldanha Viegasa Immunology and Tumor Biology Program - Research Coordination, Brazilian National Cancer Institute (INCA), Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0003-1714-4185View further author information
ORCID Icon,
Luisa Vieira Codeço Marquesa Immunology and Tumor Biology Program - Research Coordination, Brazilian National Cancer Institute (INCA), Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0003-2361-0939View further author information
ORCID Icon,
Priscila de Sousa Ferreiraa Immunology and Tumor Biology Program - Research Coordination, Brazilian National Cancer Institute (INCA), Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0001-6861-543XView further author information
ORCID Icon,
Leonardo Chicaybamb Vice-Presidency of Research and Biological Collections (VPPCB), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0002-1541-9029View further author information
ORCID Icon &
Martín Hernán Bonaminoa Immunology and Tumor Biology Program - Research Coordination, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil;b Vice-Presidency of Research and Biological Collections (VPPCB), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, BrazilCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4416-5822View further author information
ORCID Icon show all
Article: 1752592 | Received 08 Oct 2019, Accepted 31 Mar 2020, Published online: 17 Apr 2020

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Pedro Henrique Dias Moura Prazeres, Heloísa Ferreira, Pedro Augusto Carvalho Costa, Walison da Silva, Marco Túllio Alves, Marshall Padilla, Ajay Thatte, Anderson Kenedy Santos, Anderson Oliveira Lobo, Adriano Sabino, Helen Lima Del Puerto, Michael J Mitchell & Pedro Pires Goulart Guimaraes. (2023) Delivery of Plasmid DNA by Ionizable Lipid Nanoparticles to Induce CAR Expression in T Cells. International Journal of Nanomedicine 18, pages 5891-5904.
Read now

Articles from other publishers (20)

Pingfang Jiang, Pan Yang, Weijuan Wang, Jialei Cao, Wei Chen, Jianhong Fu, Lin Lu, Yin Lu & Xiaming Zhu. (2024) Management of neurotoxicity syndrome complicated by autologous hematopoietic stem cell transplantation bridge to chimeric antigen receptor T-Cell therapy: A case report. Asia-Pacific Journal of Oncology Nursing 11:3, pages 100368.
Crossref
Jakir Hossain Imran, Mohiuddin Khan Shourav & Jung Kyung Kim. (2024) Integrated Point-of-Care Immune Cell Analyzer with Rapid Blood Sample Reaction and Wide Field-of-View Detection. Analytical Chemistry 96:4, pages 1640-1650.
Crossref
Dominika Berdecka, Manon Minsart, Tao Lu, Deep Punj, Riet De Rycke, Mina Nikolić, Eduardo Bolea-Fernandez, Frank Vanhaecke, Ranhua Xiong, Stefaan C. De Smedt, Peter Dubruel, Winnok H. De Vos & Kevin Braeckmans. (2023) Photothermal nanofibers enable macromolecule delivery in unstimulated human T cells. Applied Materials Today 35, pages 101991.
Crossref
Candela Ceballos, Mª Cruz Viguria, Carlos Panizo, Juan Roberto Rodríguez-Madoz & Felipe Prósper. (2023) Mini review: Advances and challenges in CAR-T cell therapy: from early chimeric antigen receptors to future frontiers in oncology. Frontiers in Hematology 2.
Crossref
Manan Shah, Ashley Krull, Lynn Odonnell, Marcos J. de Lima & Evandro Bezerra. (2023) Promises and challenges of a decentralized CAR T-cell manufacturing model. Frontiers in Transplantation 2.
Crossref
Yan Li, Zi Wei Zeng, Di Chen, Zhi Cheng Gu, Wan Li Yan, Ling Yun Yue, Ren Guang Zhu, Yong Long Zhao, Lei Chen, Qing Jie Zhao & Bin He. (2023) Facilitated Drug Repurposing with Artemisinin-Derived PROTACs: Unveiling PCLAF as a Therapeutic Target. Journal of Medicinal Chemistry 66:16, pages 11335-11350.
Crossref
Dominika Berdecka, Aranit Harizaj, Ilia Goemaere, Deep Punj, Glenn Goetgeluk, Stijn De Munter, Herlinde De Keersmaecker, Veerle Boterberg, Peter Dubruel, Bart Vandekerckhove, Stefaan C. De Smedt, Winnok H. De Vos & Kevin Braeckmans. (2023) Delivery of macromolecules in unstimulated T cells by photoporation with polydopamine nanoparticles. Journal of Controlled Release 354, pages 680-693.
Crossref
Martín Hérnan Bonamino & Eduardo Mannarino Correia. 2023. Genome Editing in Biomedical Sciences. Genome Editing in Biomedical Sciences 59 71 .
Niki Triantafyllou, Andrea Bernardi, Matthew Lakelin, Nilay Shah & Maria M. Papathanasiou. (2022) A digital platform for the design of patient-centric supply chains. Scientific Reports 12:1.
Crossref
Prajeena Karmacharya, Basavaraj Rudragouda Patil & Jong Oh Kim. (2022) Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy. Journal of Pharmaceutical Investigation 52:4, pages 415-426.
Crossref
Alex Moretti, Marianna Ponzo, Charles A. Nicolette, Irina Y. Tcherepanova, Andrea Biondi & Chiara F. Magnani. (2022) The Past, Present, and Future of Non-Viral CAR T Cells. Frontiers in Immunology 13.
Crossref
K.S. Saini, I.M. Svane, M. Juan, F. Barlesi & F. André. (2022) Manufacture of adoptive cell therapies at academic cancer centers: scientific, safety and regulatory challenges. Annals of Oncology 33:1, pages 6-12.
Crossref
Xiuyan Wang & Isabelle Rivière. 2022. Gene and Cellular Immunotherapy for Cancer. Gene and Cellular Immunotherapy for Cancer 121 139 .
Rodrigo Nalio Ramos, Virginia Picanço-Castro, Theo Gremen M. Oliveira, Alfredo MendroneJuniorJunior, Gil Cunha De Santis, Martin Hernan Bonamino & Vanderson Rocha. (2021) Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VII. Present and future of technologies for production of CAR cell therapies. Hematology, Transfusion and Cell Therapy 43, pages S46-S53.
Crossref
Anat Globerson Levin, Isabelle Rivière, Zelig Eshhar & Michel Sadelain. (2021) CAR T cells: Building on the CD19 paradigm. European Journal of Immunology 51:9, pages 2151-2163.
Crossref
Luciana R. C. Barros, Emanuelle A. Paixão, Andrea M. P. Valli, Gustavo T. Naozuka, Artur C. Fassoni & Regina C. Almeida. (2021) CARTmath—A Mathematical Model of CAR-T Immunotherapy in Preclinical Studies of Hematological Cancers. Cancers 13:12, pages 2941.
Crossref
Srdan Rogosic & Sara Ghorashian. (2020) CAR‐T cell therapy in paediatric acute lymphoblastic leukaemia – past, present and future. British Journal of Haematology 191:4, pages 617-626.
Crossref
Karina L Hajdu & Martín H Bonamino. (2020) Senolytic chimeric antigen receptor (CAR) T cell: driving the immune system to fight cell senescence. Immunology & Cell Biology 98:9, pages 709-711.
Crossref
Leonardo Chicaybam, Martín H. Bonamino, Adriana Luckow Invitti, Patricia Bortman Rozenchan, Igor de Luna Vieira & Bryan E. Strauss. (2020) Overhauling CAR T Cells to Improve Efficacy, Safety and Cost. Cancers 12:9, pages 2360.
Crossref
Chiara F. Magnani, Sarah Tettamanti, Gaia Alberti, Ilaria Pisani, Andrea Biondi, Marta Serafini & Giuseppe Gaipa. (2020) Transposon-Based CAR T Cells in Acute Leukemias: Where Are We Going?. Cells 9:6, pages 1337.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.